Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs.
作者信息
Serei Virian D, Cristelli Ryan, Joho Kim, Salaru Gratian, Kirn Thomas, Carayannopoulous Mary O, Uprety Priyanka
机构信息
Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.
Robert Wood Johnson University Hospital, New Brunswick, NJ.
出版信息
Diagn Microbiol Infect Dis. 2021 Apr;99(4):115208. doi: 10.1016/j.diagmicrobio.2020.115208. Epub 2020 Sep 16.
Abstract
摘要
相似文献
1
Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs.雅培ID NOW新型冠状病毒肺炎快速分子检测法与赛沛Xpert Xpress新型冠状病毒检测法在干燥鼻拭子中的比较。
Diagn Microbiol Infect Dis. 2021 Apr;99(4):115208. doi: 10.1016/j.diagmicrobio.2020.115208. Epub 2020 Sep 16.
2
Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.雅培 ID Now COVID-19 快速核酸扩增检测试剂使用鼻咽拭子和干鼻拭子在纽约市学术机构中运输的病毒运输介质的性能。
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01136-20.
3
Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.Cepheid Xpert Xpress 和 Abbott ID NOW 检测试剂盒快速检测 SARS-CoV-2 的诊断准确性：系统评价和荟萃分析。
J Med Virol. 2021 Jul;93(7):4523-4531. doi: 10.1002/jmv.26994. Epub 2021 May 3.
4
Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.使用赛沛Xpert Xpress SARS-CoV-2检测系统和罗氏cobas SARS-CoV-2检测法检测严重急性呼吸综合征冠状病毒2（SARS-CoV-2）
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00772-20.
5
Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay.Cepheid Xpert® Xpress SARS-CoV-2 检测的样本混合。
Diagn Microbiol Infect Dis. 2021 Feb;99(2):115238. doi: 10.1016/j.diagmicrobio.2020.115238. Epub 2020 Oct 15.
6
Parallel testing of 241 clinical nasopharyngeal swabs for the detection of SARS-CoV-2 virus on the Cepheid Xpert Xpress SARS-CoV-2 and the Roche cobas SARS-CoV-2 assays.使用赛沛Xpert Xpress SARS-CoV-2检测系统和罗氏cobas SARS-CoV-2检测方法对241份临床鼻咽拭子进行平行检测，以检测严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒。
Clin Chem Lab Med. 2020 Nov 19;59(2):e45-e48. doi: 10.1515/cclm-2020-1338.
7
Extraction-Free Methods for the Detection of SARS-CoV-2 by Reverse Transcription-PCR: a Comparison with the Cepheid Xpert Xpress SARS-CoV-2 Assay across Two Medical Centers.通过逆转录聚合酶链反应检测严重急性呼吸综合征冠状病毒2的免提取方法：在两个医疗中心与赛沛Xpert Xpress严重急性呼吸综合征冠状病毒2检测法的比较
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02643-20.
8
Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients.雅培ID Now与雅培m2000方法用于检测有症状患者鼻咽拭子和鼻拭子中新型冠状病毒的比较。
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00798-20.
9
Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type.四项 SARS-CoV-2 核酸扩增检测（NAAT）平台的比较研究表明，ID NOW 平台的性能受到患者和标本类型的显著影响。
Diagn Microbiol Infect Dis. 2021 Jan;99(1):115200. doi: 10.1016/j.diagmicrobio.2020.115200. Epub 2020 Sep 3.
10
Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.SARS-CoV-2 大流行期间赛沛 Xpert® Xpress SARS-CoV-2 即时检测的多中心评估。
J Clin Virol. 2020 Jul;128:104426. doi: 10.1016/j.jcv.2020.104426. Epub 2020 May 11.
引用本文的文献
1
Performance evaluation of a new on-demand molecular test for the rapid identification of severe acute respiratory syndrome coronavirus 2 in pediatric and adult patients.一种用于快速鉴定儿科和成人患者中严重急性呼吸综合征冠状病毒2的新型即时分子检测方法的性能评估
Front Microbiol. 2022 Nov 3;13:999783. doi: 10.3389/fmicb.2022.999783. eCollection 2022.
2
FDA authorized molecular point-of-care SARS-CoV-2 tests: A critical review on principles, systems and clinical performances.美国食品药品监督管理局批准的分子即时检测严重急性呼吸综合征冠状病毒2检测：对原理、系统和临床性能的批判性综述。
Biosens Bioelectron X. 2022 Sep;11:100158. doi: 10.1016/j.biosx.2022.100158. Epub 2022 May 21.
3
Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay.评估当前识别（COVID-19）的能力：雅培 ID NOW COVID-19 检测的大型真实世界前瞻性评估。
Microbiol Spectr. 2022 Jun 29;10(3):e0051322. doi: 10.1128/spectrum.00513-22. Epub 2022 May 17.
4
Comparison between nucleic acid amplification tests, antigen immunofluorescence assay, and in vitro infectivity in SARS-CoV-2 diagnosis.核酸扩增检测、抗原免疫荧光分析与体外感染性在 SARS-CoV-2 诊断中的比较。
Braz J Microbiol. 2022 Sep;53(3):1271-1277. doi: 10.1007/s42770-022-00758-6. Epub 2022 Apr 21.
5
Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario.在安大略省 SARS-CoV-2 第三波疫情期间，于一家三级护理中心实施雅培 ID Now COVID-19 检测：一项前瞻性实用实施研究。
Diagn Microbiol Infect Dis. 2022 Mar;102(3):115609. doi: 10.1016/j.diagmicrobio.2021.115609. Epub 2021 Nov 27.
6
Recent findings and applications of biomedical engineering for COVID-19 diagnosis: a critical review.用于 COVID-19 诊断的生物医学工程的最新发现和应用：批判性回顾。
Bioengineered. 2021 Dec;12(1):8594-8613. doi: 10.1080/21655979.2021.1987821.
7
A brief performance evaluation and literature review of Abbott ID Now COVID-19 rapid molecular-based test.雅培 ID Now COVID-19 快速分子检测的简要性能评估和文献回顾。
J Virol Methods. 2021 Dec;298:114293. doi: 10.1016/j.jviromet.2021.114293. Epub 2021 Sep 20.
8
Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19.雅培 ID NOW 在有症状的 COVID-19 确诊患者中的可接受性能。
J Med Microbiol. 2021 Jul;70(7). doi: 10.1099/jmm.0.001372.
9
Test it earlier, result it faster, makes us stronger: how rapid viral diagnostics enable therapeutic success.检测得更早，结果更快，让我们更强：快速病毒诊断如何实现治疗成功。
Curr Opin Virol. 2021 Aug;49:111-116. doi: 10.1016/j.coviro.2021.05.007. Epub 2021 Jun 8.
10
The ID NOW COVID-19, a high-speed high-performance assay.ID NOW COVID-19，一种高速高性能检测方法。
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):2041-2045. doi: 10.1007/s10096-021-04243-0. Epub 2021 Apr 15.
Zotero 插件